Literature DB >> 21071689

Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase.

Ammon M Fager1, Jeremy P Wood, Beth A Bouchard, Ping Feng, Paula B Tracy.   

Abstract

OBJECTIVE: The goal of this study was to define and characterize the subpopulation of platelets capable of regulating the functional interactions of factors Va (FVa) and Xa (FXa) on the thrombin-activated platelet surface. METHODS AND
RESULTS: Flow cytometric analyses were used to define and characterize platelet subpopulations. At a concentration of thrombin known to elicit maximal platelet activation, platelet-derived FVa release, and prothrombinase assembly/function, only a subpopulation of platelets was positive for FVa and FXa binding. An additional subpopulation bound lower levels of FVa but little, if any, FXa. Fluorescence microscopy analyses confirmed these data. Phenotypically, platelets capable of binding FXa were more highly reticulated and demonstrated significantly increased expression of several key adhesion molecules, including P-selectin, glycoprotein Ibα, and integrins α(IIb) and β(3). This platelet subpopulation was also defined by the expression of a nondissociable, membrane-bound pool of functional platelet-derived FVa, which made up ≈35% to 50% of the total membrane-bound cofactor.
CONCLUSIONS: The ability of activated platelets to support thrombin generation is defined by a subpopulation of platelets expressing a nondissociable pool of platelet-derived FVa and increased adhesive receptor density. This subpopulation is hypothesized to play a significant role in regulating both normal hemostasis and pathological thrombus formation because the adherent properties of platelets and their ability to mount and sustain a procoagulant response are crucial steps in both of these processes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21071689      PMCID: PMC3156579          DOI: 10.1161/ATVBAHA.110.216531

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  30 in total

1.  Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin.

Authors:  L Alberio; O Safa; K J Clemetson; C T Esmon; G L Dale
Journal:  Blood       Date:  2000-03-01       Impact factor: 22.113

2.  Simultaneous engagement of thrombin and Fc gamma RIIA receptors results in platelets expressing high levels of procoagulant proteins.

Authors:  P Batar; G L Dale
Journal:  J Lab Clin Med       Date:  2001-12

3.  Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va.

Authors:  Weston R Gould; Jay R Silveira; Paula B Tracy
Journal:  J Biol Chem       Date:  2003-10-31       Impact factor: 5.157

4.  Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface.

Authors:  George L Dale; Paul Friese; Peter Batar; Stephen F Hamilton; Guy L Reed; Kenneth W Jackson; Kenneth J Clemetson; Lorenzo Alberio
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

5.  Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator.

Authors:  B Osterud; S I Rapaport; K K Lavine
Journal:  Blood       Date:  1977-05       Impact factor: 22.113

6.  Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets.

Authors:  S Karpatkin
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

7.  Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets.

Authors:  S Karpatkin
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

8.  Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT-platelets.

Authors:  Robert Szasz; George L Dale
Journal:  Blood       Date:  2002-10-15       Impact factor: 22.113

9.  A subpopulation of platelets responds to thrombin- or SFLLRN-stimulation with binding sites for factor IXa.

Authors:  Fredda S London; Mariola Marcinkiewicz; Peter N Walsh
Journal:  J Biol Chem       Date:  2004-03-09       Impact factor: 5.157

Review 10.  Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases.

Authors:  Janine M van Gils; Jaap Jan Zwaginga; Peter L Hordijk
Journal:  J Leukoc Biol       Date:  2008-10-23       Impact factor: 4.962

View more
  17 in total

1.  Procoagulant platelets form an α-granule protein-covered "cap" on their surface that promotes their attachment to aggregates.

Authors:  Anastasia A Abaeva; Matthias Canault; Yana N Kotova; Sergey I Obydennyy; Alena O Yakimenko; Nadezhda A Podoplelova; Vladimir N Kolyadko; Herve Chambost; Aleksei V Mazurov; Fazoil I Ataullakhanov; Alan T Nurden; Marie-Christine Alessi; Mikhail A Panteleev
Journal:  J Biol Chem       Date:  2013-08-30       Impact factor: 5.157

2.  Necrotic platelets provide a procoagulant surface during thrombosis.

Authors:  Vu Minh Hua; Latasha Abeynaike; Elias Glaros; Heather Campbell; Leonardo Pasalic; Philip J Hogg; Vivien M Y Chen
Journal:  Blood       Date:  2015-10-16       Impact factor: 22.113

3.  Novel Role of T Cells and IL-6 (Interleukin-6) in Angiotensin II-Induced Microvascular Dysfunction.

Authors:  Elena Y Senchenkova; Janice Russell; Alper Yildirim; D Neil Granger; Felicity N E Gavins
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

4.  Human platelets express endothelial protein C receptor, which can be utilized to enhance localization of factor VIIa activity.

Authors:  A M Fager; K R Machlus; M Ezban; M Hoffman
Journal:  J Thromb Haemost       Date:  2018-06-27       Impact factor: 5.824

5.  Prothrombin activation on the activated platelet surface optimizes expression of procoagulant activity.

Authors:  Jeremy P Wood; Jay R Silveira; Nicole M Maille; Laura M Haynes; Paula B Tracy
Journal:  Blood       Date:  2010-12-03       Impact factor: 22.113

Review 6.  Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review.

Authors:  Homam Ibrahim; Sunil V Rao
Journal:  J Thromb Thrombolysis       Date:  2017-05       Impact factor: 2.300

7.  Prothrombin activation by platelet-associated prothrombinase proceeds through the prethrombin-2 pathway via a concerted mechanism.

Authors:  Laura M Haynes; Beth A Bouchard; Paula B Tracy; Kenneth G Mann
Journal:  J Biol Chem       Date:  2012-09-18       Impact factor: 5.157

8.  Antioxidant prevents clearance of hemostatically competent platelets after long-term cold storage.

Authors:  Shailaja Hegde; Ashley M Wellendorf; Yi Zheng; Jose A Cancelas
Journal:  Transfusion       Date:  2020-11-27       Impact factor: 3.157

9.  Platelet activation in critically ill COVID-19 patients.

Authors:  Nader Yatim; Jeremy Boussier; David M Smadja; Benjamin Terrier; Richard Chocron; Jérôme Hadjadj; Aurélien Philippe; Nicolas Gendron; Laura Barnabei; Bruno Charbit; Tali-Anne Szwebel; Nicolas Carlier; Frédéric Pène; Célia Azoulay; Lina Khider; Tristan Mirault; Jean-Luc Diehl; Coralie L Guerin; Frédéric Rieux-Laucat; Darragh Duffy; Solen Kernéis
Journal:  Ann Intensive Care       Date:  2021-07-17       Impact factor: 6.925

10.  Analysis of procoagulant phosphatidylserine-exposing platelets by imaging flow cytometry.

Authors:  Emily C Reddy; Hong Wang; Hilary Christensen; Eileen McMillan-Ward; Sara J Israels; K W Annie Bang; Margaret L Rand
Journal:  Res Pract Thromb Haemost       Date:  2018-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.